AREX Capital Management’s Sotera Health SHC Stock Holding History

AREX Capital Management’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,500	Closed	-$195K	–	17
2025 Q2	$195K	Buy	+17,500	New	+$205K	0.38%	17

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

DCP

Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AREX Capital Management's SHC Position: Q3 2025 in Review

AREX Capital Management sold out of Sotera Health (SHC) in Q3 2025, closing a stake of 17,500 shares — an estimated $195K sold.

AREX Capital Management first reported a position in SHC in Q2 2025 and held it in 1 quarter. The position peaked at $195K in Q2 2025. 244 funds tracked by Wall St. Rank hold SHC as of Q3 2025.

AREX Capital Management reported no remaining Sotera Health position as of Q3 2025 after selling out during the quarter.
AREX Capital Management sold 17,500 Sotera Health shares in Q3 2025, an estimated $195K.
AREX Capital Management first reported a position in Sotera Health in Q2 2025 and held it in 1 quarter.
AREX Capital Management's Sotera Health position peaked at $195K in Q2 2025.
244 funds tracked by Wall St. Rank held Sotera Health as of Q3 2025.

Based on AREX Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.